Abstract Purpose of Review This review highlights variability in prescribing of
nonpharmacologic heart failure with reduced ejection fraction (HFrEF) therapies by race …

Background Sex and race have emerged as important contributors to the phenotypic
heterogeneity of heart failure with preserved ejection fraction (HFpEF). However, there …

Background Black individuals have a disproportionately higher burden of heart failure with
reduced ejection fraction (HFrEF) relative to other racial and ethnic populations. We …

Background: Black patients have been shown to have different baseline characteristics and
outcomes compared with nonblack patients in cohort studies. However, few studies have …

Background There are sociodemographic disparities in outcomes of heart failure with
reduced ejection fraction (HFrEF), but disparities in guideline-directed medical therapy …

Aims Recent studies have suggested potential sex differences in treatment response to
pharmacological therapies in heart failure (HF). We performed a systematic review and meta …

Abstract Purpose of Review This narrative review synthesizes sex differences in guideline-
directed medical therapy (GDMT) use and response among female patients with heart …

Objectives: This study sought to describe the health status of outpatients with heart failure
and reduced ejection fraction (HFrEF) by sex, race/ethnicity, and socioeconomic status …

In the United States, and in most of the world, women make less money and have fewer job
opportunities than men do, receive fewer college scholarships, and have more caregiving …

Background Women with heart failure with reduced ejection fraction (HFrEF) receive less
guideline-recommended therapy and experience worse quality of life than men. Objectives …